{"id":24421,"date":"2018-06-18T00:00:00","date_gmt":"2018-06-18T04:00:00","guid":{"rendered":"https:\/\/www.diabete.qc.ca\/controle-glycemique-et-pharmacotherapie-2\/"},"modified":"2023-07-25T16:17:07","modified_gmt":"2023-07-25T20:17:07","slug":"glycemic-control-and-pharmacotherapy","status":"publish","type":"page","link":"https:\/\/www.diabete.qc.ca\/en\/glycemic-control-and-pharmacotherapy\/","title":{"rendered":"Glycemic control and pharmacotherapy"},"content":{"rendered":"<div class=\"classic-block\">In the 2018 Clinical Practice Guidelines, Diabetes Canada proposes a new version of the figure that helps determine the target <a href=\"https:\/\/www.diabete.qc.ca\/fr\/comprendre-le-diabete\/tout-sur-le-diabete\/videos\/quest-ce-que-lhemoglobine-glyquee-a1c-ou-hba1c\" target=\"_blank\" rel=\"noopener noreferrer\">glycated hemoglobin (A1C)<\/a> level. This figure allows for a quick overview of different targets based on specific clinical conditions, provides an understanding of why it is important to avoid an A1C level above 8.5%, and offers recommendations for end-of-life patients.<\/p>\n<p>Source: Diab\u00e8te Canada,&nbsp;<a href=\"http:\/\/guidelines.diabetes.ca\/cpg\/chapter8\" target=\"_blank\" rel=\"noopener\">http:\/\/guidelines.diabetes.ca\/cpg\/chapter8<\/a><\/p>\n<p>In these same guidelines, Diabetes Canada has updated the therapeutic algorithm for patients with type 2 diabetes. One notable change concerns the choice of initial treatment. It now depends on each patient&#8217;s specific A1C target rather than aiming for an absolute value. Additionally, the algorithm emphasizes the importance of cardiovascular protection. Cardioprotective antidiabetic medications are introduced earlier in the treatment.<\/p>\n<p>The guidelines also highlight the relevance of reducing A1C levels while ensuring the avoidance of hypoglycemia and weight gain, especially for patients at risk of hypoglycemia or who are overweight\/obese. In fact, weight management has been added to lifestyle-focused interventions (upper part of the algorithm).<\/p>\n<p>Furthermore, insulin treatment is initiated immediately upon diagnosis in the presence of symptomatic hyperglycemia and\/or metabolic decompensation in the patient, whereas these two criteria were mandatory in the 2013 guidelines.<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>In the 2018 Clinical Practice Guidelines, Diabetes Canada proposes a new version of the figure that helps determine the target glycated hemoglobin (A1C) level. This figure allows for a quick overview of different targets based on specific clinical conditions, provides an understanding of why it is important to avoid an A1C level above 8.5%, and&hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":95,"comment_status":"closed","ping_status":"open","template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"24600,24590,24580,24572,24569,6800","_relevanssi_noindex_reason":"","footnotes":""},"class_list":["post-24421","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/pages\/24421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/comments?post=24421"}],"version-history":[{"count":5,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/pages\/24421\/revisions"}],"predecessor-version":[{"id":31031,"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/pages\/24421\/revisions\/31031"}],"wp:attachment":[{"href":"https:\/\/www.diabete.qc.ca\/en\/wp-json\/wp\/v2\/media?parent=24421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}